Trial intelligence / Profile preview

Xuesaitong enteric-coated tablets vs Xuesaitong tablets in cerebral infarction

CTR20130592Phase 2Completed

Sponsor
Weihe Pharmaceutical
Start
May 2014
Countries
1
01

Overview

A Phase 2 trial of panax notoginseng in brain infarction, sponsored by Weihe Pharmaceutical. Started May 2014; status: completed.

02

Drugs

panax notoginseng
03

Conditions

brain infarction

Beyond the preview

Go deeper on CTR20130592.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20130592.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call